Mcf Advisors LLC Oyster Point Pharma, Inc. Transaction History

Mcf Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$8.58 - $17.65 $9,197 - $18,920	1,072 New	1,072 $12,000
Q4 2021 Feb 14, 2022	SELL	$10.17 - $18.96 $10,902 - $20,325	-1,072 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$18.13 - $25.18 $127,997 - $177,770	-7,060 Reduced 86.82%	1,072 $20,000
Q2 2020 Aug 11, 2020	SELL	$27.86 - $35.93 $330,642 - $426,417	-11,868 Reduced 59.34%	8,132 $235,000
Q1 2020 Apr 24, 2020	BUY	$23.65 - $40.96 $473,000 - $819,200	20,000 New	20,000 $700,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.